Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

[1]  R. Challiss,et al.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. , 1991, TIPS - Trends in Pharmacological Sciences.

[2]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[3]  T. Torphy,et al.  Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. , 1990, Molecular pharmacology.

[4]  E. Sybertz,et al.  Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. , 1989, Biochemical pharmacology.

[5]  M. Leroy,et al.  Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. , 1989, Biochemical pharmacology.

[6]  R. Bentley,et al.  Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. , 1988, European journal of pharmacology.

[7]  Beavo Ja.  Multiple isozymes of cyclic nucleotide phosphodiesterase. , 1988 .

[8]  J. Beavo.  Multiple isozymes of cyclic nucleotide phosphodiesterase. , 1988, Advances in second messenger and phosphoprotein research.

[9]  P. J. England,et al.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. , 1987, The Biochemical journal.

[10]  T. Rall.  Formation and Degradation of Cyclic Nucleotides: An Overview , 1982 .

[11]  M. Ferrari.  Effects of papaverine on smooth muscle and their mechanisms. , 1974, Pharmacological research communications.

[12]  G. Brooker,et al.  Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. , 1974, Methods in enzymology.

[13]  G. A. Thompson,et al.  Membrane formation in Tetrahymena pyriformis. 4. Lipid composition and biochemical properties of Tetrahymena pyriformis membrane systems , 1971 .

[14]  G. Pöch,et al.  Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.

[15]  Thompson Wj,et al.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain , 1971 .